Molbio Diagnostics experienced a sharp decline, dropping 8.8% to ₹1,229.65 on September 16, following profit booking after significant gains. Despite the recent downturn, the stock remains over 50% above its IPO price of ₹807, having surged 75% in the last month.
Molbio Diagnostics experienced a sharp decline, dropping 8.8% to ₹1,229.65 on September 16, following profit booking after significant gains. Despite the recent downturn, the stock remains over 50% above its IPO price of ₹807, having surged 75% in the last month.
<iframe src="https://hindustansphere.com/embed/cluster/6a2861f3fc082fc08cc7f1f52f144247735eb221" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Recently listed Molbio Diagnostics share price falls 9%: Healthcare stock loses 18.5% in 2 days after blockbuster rally"></iframe>
